Home
Conditions
Burkitt Lymphoma

Clinical trial condition

Burkitt Lymphoma

Explore clinical trials studying Burkitt Lymphoma. Study availability and eligibility vary by location and protocol.

695 public trials 115 recruiting studies

Refine in advanced search Browse all conditions

Burkitt Lymphoma trial results

Not Yet Recruiting

Non-Interventional Study of Puzol-cel for CD19-Positive Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

NCT07637929

Conditions: Burkitt Lymphoma, DNA Virus Infections, Disease Attributes, +19 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute Lymphoblastic Leukemia With a Genetic Change Requiring More Treatment

NCT07636564

Conditions: Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, +24 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

CAR-T Treatment in Pediatric and Adult Acute Lymphoblastic Leukemia

NCT07623655

Conditions: Acute Lymphoblastic Leukemia, B-Cell Acute Lymphoblastic Leukaemia, Burkitt Lymphoma, +20 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Evaluation of the Safety and Efficacy of Sup19 CAR-T Cells in Patients With Previously Failed CD19-Targeted Therapy or CD19-Weakly Expressed Hematologic Tumors

NCT07539610

Conditions: B Acute Lymphoblastic Leukemia/Lymphoma, B-Acute Lymphoblastic Leukemia, Burkitt Lymphoma, +16 more
Locations: Institute of Hematology, Chinese Academy of Medical Sciences & Hospital of Hematology, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China

View Trial Details

Not Yet Recruiting

International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)

NCT07476729

Conditions: B-Cell Acute Lymphoblastic Leukaemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: St. Anna Kinderspital GmbH Vienna, Austria

Ghent University Hospital Ghent, Belgium

Fakultni Nemocnice V Motole Prague, Czechia

Rigshospitalet Copenhagen, Denmark

View all 20 locations

View Trial Details

Not Yet Recruiting

This Clinical Trial is a Single-arm, Non-randomized Pilot Trial to Determine the Safety of Administering Autologous Anti-C19 Cells (ARI-0001) and the Feasibility of Local CAR-T Cell Production in Patients Over 18 Years of Age With Relapsed/Refractory (R/R) CD19+ Hematologic Malignancies, Including R

NCT07412405

Conditions: Adult B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Chronic Disease, +31 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Autologous Bedside CD19 CAR T-cell Therapy for B-ALL

NCT07277504

Conditions: B-Cell Acute Lymphoblastic Leukemia, Adult, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: The General Hospital of Western Theater Command Chengdu, Sichuan, China

View Trial Details

Not Yet Recruiting

Allogeneic UCB-derived CAR-T for B-ALL

NCT07256353

Conditions: B-Cell Acute Lymphoblastic Leukemia, Adult, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: The General Hospital of Western Theater Command Chengdu, Sichuan, China

View Trial Details

Not Yet Recruiting

A Clinical Study to Explore CT1195E in Patients With Relapsed/Refractory B-Cell Neoplasms

NCT07234045

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +16 more
Locations: China Institute of Hematology and Blood Diseases Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Not Yet Recruiting

Novel Bispecific AbTCR (Anti-CD19/CD22)-T Cells in Relapsed or Refractory B-cell Lymphoma

NCT07168291

Conditions: Burkitt Lymphoma, DNA Virus Infections, Diffuse Large B Cell Lymphoma (DLBCL), +18 more
Locations: First Affiliated Hospital of Xi'an Jiaotong University Xi'an, Shaanxi, China

View Trial Details

Burkitt Lymphoma

Burkitt Lymphoma trial results

Related conditions